Columbia University

Technology Ventures

Latest News

For three years, the Columbia-Coulter Translational Research Partnership has provided up to $1 million per year to bring innovative biomedical technologies to market to benefit human health and society through a unique collaboration between the Wallace H. Coulter Foundation and Columbia University’s Departments of Biomedical Engineering (BME), Surgery, Orthopaedic Surgery, Radiology, and Columbia Technology Ventures.
Researchers at the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health identified distinct immune changes in patients diagnosed with chronic fatigue syndrome, known medically as myalgic encephalomyelitis (ME/CFS) or systemic exertion intolerance disease.
The U.S. Department of Commerce and Columbia University today announced that they will co-host the first-ever Future of Urban Innovation Summit, which will take place at the Columbia University campus in New York City on Tuesday, June 9, 2015.
Read CTV Executive Director Orin Herskowitz's letter from our March 2015 newsletter.
As the leader of the nation’s only lab to combine research in speech recognition, music processing, signal separation, and content-based retrieval for sound processing in machines, Prof. Dan Ellis is making a lot of noise.
Researchers have for the first time successfully converted adult human skin cells into neurons of the type that regulate appetite, providing a patient-specific model for studying the neurophysiology of weight control and testing new therapies for obesity.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
See Columbia start-up LuminAID on ABC's Shark Tank!
And now, a three-part, six-hour documentary series based on Siddhartha Mukherjee’s book “The Emperor of All Maladies: A Biography of Cancer” debuts on PBS stations March 30 and continues on March 31 and April 1.
Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.